DLP PVC Left Heart Vent; DLP Malleable PVC Left Heart Vent; DLP Silicone Left Heart Vent
Medtronic · Decision date Oct 23, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on 10/23/2026 for K261792, a traditional 510(k) submitted by Medtronic of Mounds View, MN, with a receipt date of 05/29/2026. The listed device names are DLP PVC Left Heart Vent, DLP Malleable PVC Left Heart Vent and DLP Silicone Left Heart Vent. SESE means the submission was cleared as substantially equivalent; it is not a PMA approval. The page lists the review panel as Cardiovascular and states the submission was not reviewed by a third party, was not a combination product and had no authorized predetermined change control plan.
The record does not state which of the three named devices was the subject of the submission, nor does it identify a predicate device, a cleared-to-marketed change, or any specific component or material modification. The public page also does not give a product code, regulation number or device class, and the specialty field is recorded as Unknown. No summary of safety and effectiveness or decision statement is included in the available text, so the basis for the equivalence finding and any labeling or indication details remain unverified here.
Industry researchers should treat this as a dated clearance record only. The page was last updated 10/26/2026, and no clinical, efficacy or patient-selection conclusions can be drawn from the fields shown.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Unknown
- Decision date
- Oct 23, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K261792
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Medtronic
- Product code
- Not reported
- Decision code
- SESE
- Decision date
- Oct 23, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
- Applicant
- Medtronic
- Product code
- Not reported
FDA decision timeline
K261792 received
Application receipt date recorded by FDA.
K261792 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Medtronic
- Headquarters
- Not reported
- Brand website
- medtronic.com
- FDA applicant address
- Mounds View, MN
Sources and methodology
- Original FDA record: K261792
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records